Prehospital Air Medical Plasma (PAMPer) Trial
Abstract
To determine the effect of the prehospital infusion (i.e., during air medical transport) of AB plasma or low titer anti-B A plasma (2 units) on 30 day mortality in patients with hemorrhagic shock as compared to standard air medical care. Determine whether prehospital infusion of AB plasma or low titer anti-B A plasma (2 units) as compared to standard air medical care results in a reduction in 30 day mortality. Determine whether prehospital infusion of AB plasma or low titer anti-B A plasma as compared to standard air medical care results in a lower 24 hour blood transfusion requirement, a lower incidence of multiple organ failure, nosocomial infection, acute lung injury and TRALI.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2015
- Accession Number
- AD1002954
Entities
People
- Ashley Ryman
- Barbara J. Early
- Jason Sperry
- Meghan Buck
Organizations
- University of Pittsburgh